Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/25/20
End: 12/15/23
Due: 12/15/24
Phase: N/A
Priority: Normal
Start: 05/04/20
End: 12/15/23
Due: 12/15/24
Phase: N/A
Priority: Normal
Start: 07/12/22
End: 06/30/26
Due: 06/30/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants | NCT04487405 | Aspira Women's Health | user2@example.com | None | 2020-06-25 | 2023-12-15 | 2024-12-15 | - | - | 2025-07-14 |
| Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection | NCT04668521 | Aspira Women's Health | user2@example.com | None | 2020-05-04 | 2023-12-15 | 2024-12-15 | - | - | 2025-07-14 |
| Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck) | NCT05245695 | Aspira Women's Health | user2@example.com | None | 2022-07-12 | 2026-06-30 | 2027-06-30 | - | - | 2025-07-14 |